business

business

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications - investor.lilly.com

Triumph-1 Study Results: Significant Weight Loss and Improved Health Outcomes with Retrutide The Triumph-1 study is a groundbreaking clinical trial that has achieved remarkable results in weight loss and improved health outcomes for participants treated with retetrutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. The study&

By Tornado

business

San Francisco-based Anthropic calls for global freeze on AI development, warns that AI could soon escape human control - ABC7 Bay Area

The Rise of Self-Improving AI Models: A New Era in Artificial Intelligence In recent years, artificial intelligence (AI) models have made tremendous progress in various fields, including natural language processing, computer vision, and machine learning. The latest advancements in AI technology have led to the development of more sophisticated

By Tornado